drugset / Trial / NCT04029766
A Study Evaluating Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of HSK3486 Single Bolus Dose Followed With a 30 Minute Constant Infusion in Healthy Male Subjects
NaSingle-groupOpen-labelTreatment
Summary
This study was a single center, open-label, single dose escalation study in healthy male subjects to investigate a bolus dose followed by a 30 minute constant infusion of HSK3486 over two cohorts.
Timeline
- Start
- 2015-11-10
- Primary completion
- 2015-12-14
- Completion
- 2016-06-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cipepofol | Small molecule | 1 mg/kg | — |
| Subject | Cipepofol | Small molecule | 2 mg/kg | — |
Indications
No indication recorded.